中文

Your Pharmaceutical Solid State Research Partner

Molecules-to-Medicine: Accelerating Drug Development through Collaboration

Crystal Pharmatech is pleased to announce our new webinar series: "Molecules-to-Medicine: Accelerating Drug Development through Collaboration".

Purpose: To communicate the extraordinary ingenuity taking place in 21st century drug discovery and development and that a good idea is just the first step in creating a medicine. In a nutshell, why CMC matters and how collaboration can accelerate development.

Presenters: Innovative pharmaceutical scientists and entrepreneurs showcasing novel therapeutic technologies with a focus on how a molecule becomes a medicine.

  • Thursday, April 22, 2021, at 1:00 PM
    • Title: The purpose behind "Molecules-to-Medicine: Accelerating Drug Development through Collaboration"
      • Webinar Series Kickoff - Panel Discussion
    • Panel:
      • Robert Wenslow, Ph.D. (Head US Operations, Crystal Pharmatech)
      • Yongqiang Li, Ph.D. (CEO, Candoo Pharmatech)
      • Joe Armstrong, Ph.D. (COO, TCG Green Chem)
      • Chris Senanayake, Ph.D. (CEO/CSO, TCG Green Chem)
    • Registration Link: https://attendee.gotowebinar.com/register/3785395746960239120>
  • Wednesday, May 19, 2021, at 1:00 PM